What is Optain?
Optain Health operates at the intersection of artificial intelligence and medical technology, focusing on the critical area of early disease detection. The company's proprietary platform leverages sophisticated AI algorithms to interpret retinal scans, a non-invasive method that can reveal early indicators of various ocular pathologies and broader systemic health issues. By providing healthcare professionals with advanced analytical tools, Optain aims to revolutionize preventative care and improve patient outcomes through timely and accurate diagnoses.
How much funding has Optain raised?
Optain has raised a total of $38M across 2 funding rounds:
Angel/Seed
$12M
Series A
$26M
Angel/Seed (2023): $12M, investors not publicly disclosed
Series A (2025): $26M led by Insight Partners
Key Investors in Optain
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies. It provides capital and hands-on operational support to help businesses scale from early stage to IPO, focusing on enterprise software, SaaS, and internet platforms.
What's next for Optain?
The substantial enterprise-level backing and recent strategic investment signal a strong market validation for Optain's innovative approach to medical diagnostics. This capital infusion is expected to fuel the company's expansion into new markets, accelerate research and development for enhanced AI capabilities, and scale its operational infrastructure. Optain is poised to solidify its position as a leader in AI-driven retinal imaging, driving advancements in preventative healthcare and disease management globally.
See full Optain company page
